Archive: August, 2011

The Advocate General provides guidance on supplementary protection certificates for combination products

The Advocate General provides guidance on supplementary protection certificates for combination products

The Advocate General (AG) has opined on two references from the UK on the application of the Supplementary protection certificates (SPC) Regulations (Regulation 469/2009) to combination products (Medeva BV v Comptroller-General of Patents, Designs and Trade Marks (Case C-322/10) and Georgetown University, University of Rochester,Loyola University of Chicago v Comptroller-General of Patents, Designs and Trade […]

The Advocate General (AG) has opined on two references from the UK on the application of the Supplementary protection certificates (SPC) Regulations (Regulation 469/2009) to combination products (Medeva BV v Comptroller-General of Patents, Designs and Trade Marks (Case C-322/10) and Georgetown University, University of Rochester,Loyola University of Chicago v Comptroller-General of Patents, Designs and Trade […]
Myriad CAFC Panel Decision

Myriad CAFC Panel Decision

A panel of the Court of Appeals for the Federal Circuit (CAFC) rendered a decision today, in the Myriad case, regarding patent eligibility of “isolated” DNA molecules.  See  Association for Molecular Pathology v. PTO, posted at http://www.cafc.uscourts.gov/images/stories/opinions-orders/10-1406.pdf. The CAFC panel reversed the District court’s decision that had held Myraid’s claims to “isolated” DNA patent ineligible.  In […]